Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: A prospective, long-term, followup study

Arthritis Care and Research

Volumn 53, Issue 3, 2005, Pages 460-467

  Perez Villa, Felix ^a   Font, Josep ^a   Azqueta, Manel ^a   Espinosa, Gerard ^a   Pare, Carles ^a   Cervera, Ricard ^a   Reverter, Joan C ^a   Ingelmo, Miguel ^a   Sanz, Gines ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid; Systemic lupus erythematosus; Valvular regurgitation

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ARTICLE; DEATH; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EMBOLISM; FEMALE; FOLLOW UP; HEART VALVE REGURGITATION; HEART VALVE REPLACEMENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HUMANS; IMMUNOGLOBULIN G; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 20444368056     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21162     Document Type: Article

References (50)

1. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-del-Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Eng J Med 1988;319:817-23.
2. Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies. Circulation 1990;82:369-75.
3. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541-4.
4. Cervera R, Font J, Pare C, Azqueta M, Perez-Villa F, Lopez-Soto A, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992;51:156-9.
5. Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992;20:1127-34.
6. Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993;125:1123-9.
7. Jouhikainen T, Pohjola-Sintonen S, Stephansson E. Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus 1994;3:167-72.
8. Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, López-Soto A, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994;96:3-9.
9. Gabrielli F, Alcini E, di Prima MA, Mazzacurati G, Masala C. Cadiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 1995;51:117-26.
10. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424-30.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. Brandt JT, Triplett DA, Alving B, Scharrer I, and the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-90.
13. Eisenberg MJ, Oken K, Guerrero S, Saniei MA, Schiller NB. Prognostic value of echocardiography in hospitalized patients with pericardial effusion. Am J Cardiol 1992;70:934-9.
14. Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-83.
15. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al, and the American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
16. Myerowitz PD, Michaelis LL, McIntosh CL. Mitral valve replacement for mitral regurgitation due to Libman-Sacks endocarditis: report of a case. J Thorac Cardiovasc Surg 1974;67:869-74.
17. Murray FT, Fuleihan DS, Cornwall CS, Pinals RS. Acute mitral regurgitation from ruptured chordae tendineae in systemic lupus erythematosus. J Rheumatol 1975;2:454-9.
18. Yates DB, Scott JT. Cardiac valvular disease in chronic inflammatory disorders of connective tissue: factors influencing survival after surgery. Ann Rheum Dis 1975;34:321-5.
19. Bulkey BH, Roberts WC. Systemic lupus erythematosus as a cause of severe mitral regurgitation: new problem in an old disease. Am J Cardiol 1975;35:305-8.
20. Paget SA, Bulkley BH, Grauer LE, Seningen R. Mitral valve disease of systemic lupus erythematosus: a cause of severe congestive heart failure reversed by valve replacement. Am J Med 1975;59:134-9.
21. Mossard JM, Walter P, Brechenmacher C, Voegtlin R. Cardiac involvement in a lupus syndrome: clinical and morphological study apropos of one case necessiting a double valve replacement. Arch Mal Coeur Vaiss 1977;70:1203-8. In French.
22. Vaughton KC, Walker DR, Sturridge MF. Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis. Br Heart J 1979;41:730-3.
23. Kinney EL, Wynn J, Ward S, Babb JD, Wine-Shaffer C, Zelis R. Ruptured chordae tendineae: its association with systemic lupus erythematosus. Arch Pathol Lab Med 1980;104:595-6.
24. Milne JR, Doyle DV, Banim SE, Huskisson EC. Systemic lupus erythematosus as a cause of severe mixed mitral valve disease. J Rheumatol 1981;8:516-8.
25. Rawsthorne L, Ptacin MJ, Choi H, Olinger GN, Bamrah VS. Lupus valvulitis necessitating double valve replacement. Arthritis Rheum 1981;24:561-4.
26. Evans DT, Sloman JG. Mitral stenosis and mitral incompetence due to Libman-Sacks endocarditis with mitral valve replacement. Aust N Z J Med 1981;11:526-8.
27. Dajee H, Hurley EJ, Szarnicki RJ. Cardiac valve replacement in systemic lupus erythematosus: a review. J Thorac Cardiovasc Surg 1983;85:718-26.
28. Brennan FJ, Ford SE, Ford PM, Morrin PA, Burggraf GW, Salerno TA. Mitral regurgitation due to lupus endocarditis treated with valve replacement. Can Med Assoc J 1983;129:584-7.
29. Sanchez G, Lintermans J, Sambon F, Jaumin P, Gosseye S, Tremouroux M, et al. Mitral valve replacement in an infant with disseminated lupus erythematosus and Libman-Sacks endocarditis. Arch Mal Coeur Vaiss 1983;76:622-6. In French.
30. Moynihan T, Hansen R, Troup P, Olinger G. Simultaneous aortic and mitral valve replacement for lupus endocarditis: report of a case and review of the literature. J Thorac Cardiovasc Surg 1988;95:142-5.
31. Ford PM, Ford SE, Lillicrap DP. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol 1988;15:597-600.
32. Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 1988;85:645-50.
33. Ferraris VA, Hawksley VC, Rabinowitz M, Coyne CM, Sullivan TJ, Sprague MS. Double valve replacement for lupus valvulitis: report of a case and review of the literature. Tex Heart Inst J 1990;17:56-60.
34. Hachulla E, Bataille D, Janin A, Gilliot JM, Gosset D, Warembourg H, et al. Double heart valve replacement disclosing antiphospholipid syndrome. Rev Med Interne 1992;13:221-4. In French.
35. Alameddine AK, Schoen FJ, Yanagi H, Couper GS, Collins JJ Jr, Cohn LH. Aortic or mitral valve replacement in systemic lupus erythematosus. Am J Cardiol 1992;70:955-6.
36. Durand I, Blaysat G, Chauvaud S, Tron P, Tron F, Mallet E, et al. Extensive fibrous endocarditis as first manifestation of systemic lupus erythematosus. Arch Fr Pediatr 1993;50:685-8. In French.
37. Kalangos A, Panos A, Sezerman O. Mitral valve repair in lupus valvulitis: report of a case and review of the literature. J Heart Valve Dis 1995;4:202-7.
38. Chauvaud SM, Kalangos A, Berrebi AJ, Gaer AR, Acar C, Carpentier AF. Systemic lupus erythematosus valvulitis: mitral valve replacement with a homograft. Ann Thorac Surg 1995;60:1803-5.
39. Gordon RJ, Weilbaecher D, Davy SM, Safi HJ, Quinones MA, DeFelice CA, et al. Valvulitis involving a bioprosthetic valve in a patient with systemic lupus erythematosus. J Am Soc Echocardiogr 1996;9:104-7.
40. Morin AM, Boyer AS, Nataf P, Gandjbakhch I. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg 1996;44:313-6.
41. Hakim JP, Mehta A, Jain AC, Murray GF. Mitral valve replacement and repair: report of 5 patients with systemic lupus erythematosus. Tex Heart Inst J 2001;28:47-52.
42. Yoshida M, Sasako Y, Kobayashi J, Minatoya K, Bando K, Kitamura S. Mitral valve plasty in systemic lupus erythematosus in the setting of antiphospholipid syndrome. Jpn J Thorac Cardiovasc Surg 2000;48:391-3.
43. Kato Y, Isobe F, Sasaki Y, Kumano H, Nagamachi K, Arimoto H. Secondary mitral valve replacement in antiphospholipid syndrome and chronic renal failure. Jpn J Thorac Cardiovasc Surg 2001;49:728-31.
44. Moyssakis I, Tzioufas A, Triposkiadis F, Strateges N, Kyriakidis M. Severe aortic stenosis and mitral regurgitation in a woman with systemic lupus erythematosus. Clin Cardiol 2002;25:194-6.
45. Chauvaud S, Waldmann T, d'Attellis N, Bruneval P, Acar C, Gerota J, et al. Homograft replacement of the mitral valve in young recipients: mid-term results. Eur J Cardiothorac Surg 2003;23:560-6.
46. Georghiou GP, Shapira Y, Drozd T, Erez E, Raanani E, Vidne BA, et al. Double-valve Libman-Sacks endocarditis: an entity that demands special consideration. J Heart Valve Dis 2003;12:797-801.
47. Erkan D, Leibowitz E, Berman J, Lockshin MD. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol 2002;29:843-9.
48. Ciocca RG, Choi J, Graham AM. Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg 1995;170:198-200.
49. Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, et al. Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998;98:1949-84.
50. Lockshin M, Tenedios F, Petri M, McCarty G, Forastiero R, Krilis S, et al. Cardiac disease in the antiphospholipid syndrome: recommendations for treatment: committeee consensus report. Lupus 2003;12:518-23.